Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), 50S subunit inhibitors(50S ribosomal subunit inhibitors), CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) + [2] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H38Cl2N8O4 |
InChIKeyVHVPQPYKVGDNFY-WGEGMAFPSA-N |
CAS Registry84625-61-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic foot ulcer | Phase 1 | United States | 31 Mar 2021 |